Augmentation of tumor immune response by depletion of regulatory T cells
Project/Area Number |
25430161
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Tumor therapeutics
|
Research Institution | Kawasaki University of Medical Welfare |
Principal Investigator |
NAKAYAMA EIICHI 川崎医療福祉大学, 医療福祉学部, 教授 (60180428)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | がん免疫 / 腫瘍内浸潤リンパ球 / 制御性T細胞 / ケモカイン受容体CCR4 / ケモカインCCL22/MDC / 抗体依存性細胞障害性(ADCC) / ヒト化抗CCR4単クローン抗体 / 制御性T細胞除去 / ADCC活性 / 遊走 / 肺癌 / 肺がん / ケモカイン受容体 |
Outline of Final Research Achievements |
Augmentation of tumor immune response by depletion of regulatory T cells (Tregs) was pursued by the following studies. 1. On three Treg subpopulations, resting Tregs, activated Tregs and nonTregs, difference of the expression of CCR4 chemokine receptor on their surface and of their distribution in PBMC and TIL was demonstrated. 2. The presence of CCR4-expressing Tregs and CCL22/MDC in the local tumor site was shown by immunohistochemistry. 3. CD25 CD4 Tregs with migratory activity were shown to be eliminated by CCR4(KM2760)mAb with antibody-dependent cell-mediated cytotoxicity(ADCC). 4. Efficient depletion of Tregs by injection of humanized anti-CCR4( KW-0761)mAb in solid cancer patients was demonstrated.
|
Report
(4 results)
Research Products
(73 results)
-
-
-
-
[Journal Article] Sensitive multiplexed quantitative analysis of autoantibodies to cancer antigens with chemically S-cationized full-length and water-soluble denatured proteins.2015
Author(s)
Futami J, Nonomura H, Kido M, Niidoi N, Fujieda N, Hosoi A, Fujita K, Mandai K, Atago Y, Kinoshita R, Honjo T, Matsushita H, Uenaka A, Nakayama E, and Kakimi K.
-
Journal Title
Bioconjugate Chem.
Volume: 26(10)
Issue: 10
Pages: 2076-2084
DOI
Related Report
Peer Reviewed
-
[Journal Article] Contrasting effects of the cytotoxic anticancer drug Gemcitabine and the EGFR tyrosine kinase inhibitor Gefitinib on NK cell-mediated cytotoxicity via regulation of NKG2D ligand in non-small-cell lung cancer cells.2015
Author(s)
Okita R, Wolf D, Yasuda K, Maeda A, Yukawa T, Saisho S, Shimizu K, Yamaguchi Y, Oka M, Nakayama E, Lundqvist A, Kiessling R, Seliger B, Nakata M.
-
Journal Title
PLoS One
Volume: 10
Issue: 10
Pages: e0139809-e0139809
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients.2015
Author(s)
2.Kurose K, Ohue Y, Wada H, Iida S, Ishida T, Kojima T, Doi T, Suzuki S, Isobe M, Funakoshi T, Kakimi K, Nishikawa H, Udono H, Oka M, Ueda R, Nakayama E.
-
Journal Title
Clin Cancer Res.
Volume: 21
Issue: 19
Pages: 4327-36
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] Detection and Tracking of NY-ESO-1-Specific CD8+ T Cells by High-Throughput T Cell Receptor β (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient.2015
Author(s)
Miyai M, Eikawa S, Hosoi A, Iino T, Matsushita H, Isobe M, Uenaka A, Udono H, Nakajima J, Nakayama E, Kakimi K.
-
Journal Title
PLoS One
Volume: 10(8)
Issue: 8
Pages: e0136086-e0136086
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
[Journal Article] Vaccination With NY-ESO-1 Overlapping Peptides Mixed With Picibanil OK-432 and Montanide ISA-51 in Patients With Cancers Expressing the NY-ESO-1 Antigen2014
Author(s)
Wada H, Isobe M, Kakimi K, Mizote Y, Eikawa S, Sato E, Takigawa N, Kiura K, Tsuji K, Iwatsuki K, Yamasaki M, Miyata H, Matsushita H, Udono H, Seto Y, Yamada K, Nishikawa H, Pan L, Venhaus R, Oka M, Doki Y, Nakayama E.
-
Journal Title
J Immunother
Volume: 37(2)
Issue: 2
Pages: 84-92
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimide-dextran (NPCMD).2014
Author(s)
Mizote, Y., Wakamatsu, K., Ito, S., Uenaka, A., Ohue, Y., Kurose, K., Isobe, M., Ito, A., Tamura, Y., Honda, H., Yamashita, T., Nohara, S., Oka, M., Jimbow, K., Nakayama, E.
-
Journal Title
J. Dermatol. Sci.
Volume: 73
Issue: 3
Pages: 76-87
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein.2013
Author(s)
Reis BS, Jungbluth AA, Frosina D, Holz M, Ritter E, Nakayama E, Ishida T, Obata Y, Carver B, Scher H, Scardino P, Slovin S, Subudhi SK, Reuter VE, Savage C, Allison JP, Melamed JM, Jager E, Ritter G, Old LJ, Gnjatic S.
-
Journal Title
Clin. Cancer Res.
Volume: 19(22)
Issue: 22
Pages: 6112-6125
DOI
Related Report
Peer Reviewed
-
[Journal Article] Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?2013
Author(s)
Takaki A, Yagi T, Yasunaka T, Sadamori H, Shinoura S, Umeda Y, Yoshida R, Sato D, Nobuoka D, Utsumi M, Yasuda Y, Nakayama E, Miyake Y, Ikeda F, Shiraha H, Nouso K, Fujiwara T, Yamamoto K
-
Journal Title
J Gastroenterol
Volume: 48(12)
Issue: 12
Pages: 1373-1383
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] T-cell receptor repertoires of tumor-infiltrating lymphocytes after hyperthermia using functionalized magnetite nanoparticles2012
Author(s)
Ito A, Yamaguchi M, Okamoto N, Sanematsu Y,Kawabe Y, Wakamatsu K, Ito S, Honda H, Kobayashi T, Nakayama E, Tamura Y, Okura M, Yamashita T, Jimbow K, Kamihara M
-
Journal Title
Nanomedicine
Volume: (epub ahead of print)
Issue: 6
Pages: 891-902
DOI
Related Report
Peer Reviewed
-
-
-
[Presentation] Phase I a study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients2015
Author(s)
黒瀬浩史, 大植祥弘, 和田尚, 飯田真介, 石田高司, 鈴木進, 垣見和宏, 西川博嘉, 上田龍三, 岡三喜男, 中山睿一
Organizer
第74回日本癌学会学術総会
Place of Presentation
名古屋国際会議場(名古屋)
Year and Date
2015-10-08
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb.2013
Author(s)
Kurose K, Eikawa S, Mizote Y, Ohue Y, Isobe M, Uenaka A, Oka M, Nakayama E.
Organizer
104nd Annual Meeting of American Association of Cancer Research (AACR)
Place of Presentation
Walter E. Washington Convention Center (801 Mt. Vernon Place NW, Washington, DC, USA)
Related Report
-
[Presentation] Immune response to XAGE-1b (GAGED2a) in NSCLC patients and its clinical relevance.2013
Author(s)
Ohue Y, Kurose K, Eikawa S, Mizote Y, Matsumoto H, Isobe M, Uenaka A, Fukuda M, Nakayama E, Oka M.
Organizer
104nd Annual Meeting of American Association of Cancer Research (AACR)
Place of Presentation
Walter E. Washington Convention Center (801 Mt. Vernon Place NW, Washington, DC, USA)
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-